SEC Form 4/A · accession 0000904454-16-000916
Paratek Pharmaceuticals, Inc. · PRTK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Douglas W. Pagan
Officer — Chief Financial Officer
Period of report
Feb 4, 2015
Accepted (ET)
Feb 8, 2016 · 5:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178711
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 4, 2015 | A | 35,000 | $0.00 | A | 35,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The restricted stock units ("RSUs") underlying these shares were previously reported as derivative securities in Table II of the Reporting Person's original Form 4 filed with the Securities and Exchange Commission on February 6, 2015. This amendment is being made to report such RSUs in Table I due to the fact that such RSUs are time-based and settled in Common Stock.
- F2The shares shall vest in full (100%) on the three-year anniversary of the date of grant, subject to continued service with the Company.
Remarks
Remarks: Exhibit List: Exhibit 24 - Power of Attorney